# Study That Tests AD109 in Patients Taking GLP-1 Drugs

> **NCT06400615** · PHASE2 · COMPLETED · sponsor: **Apnimed** · enrollment: 40 (actual)

## Conditions studied

- OSA

## Interventions

- **DRUG:** AD109

## Key facts

- **NCT ID:** NCT06400615
- **Lead sponsor:** Apnimed
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-05-20
- **Primary completion:** 2024-12-26
- **Final completion:** 2024-12-26
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2025-02-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06400615

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06400615, "Study That Tests AD109 in Patients Taking GLP-1 Drugs". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT06400615. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*